NRX Pharmaceuticals Inc NRXP

US Pharmaceuticals

$2.36 ▼ -0.84% ($-0.02)

🔥 High Short Interest 🎢 High Beta 📅 Earnings This Week

Open $2.36

Prev Close $2.38

Day Range $2.29 – $2.40

52W Range $1.62 – $5.06

Market Cap $103.88M

Beta 2.14

EPS (TTM) $-0.74

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2017-11-20
Shares Out.	43,300,000
Website	nrxpharma.com ↗
Phone	13025750877
Employees	29
Revenue	$1.1M
Gross Profit	$426,000
Net Income	-$16.5M
Free Cash Flow	-$20.7M
Total Assets	$34.2M
Total Liabilities	$34.3M
Equity	-$170,000

About NRX Pharmaceuticals Inc

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

NRX Pharmaceuticals Inc is a publicly traded company under the ticker symbol NRXP on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.